96 related articles for article (PubMed ID: 8872322)
1. An enzyme-linked immunosorbent assay for the determination of src-family tyrosine kinase activity in breast cancer.
Rijksen G; Adriaansen-Slot SS; Staal GE
Breast Cancer Res Treat; 1996; 39(2):139-45. PubMed ID: 8872322
[TBL] [Abstract][Full Text] [Related]
2. Standardization of an enzyme-linked immunosorbent assay for the determination of protein tyrosine kinase activity.
Schraag B; Staal GE; Adriaansen-Slot SS; Salden M; Rijksen G
Anal Biochem; 1993 Jun; 211(2):233-9. PubMed ID: 7686354
[TBL] [Abstract][Full Text] [Related]
3. A synthetic peptide derived from p34cdc2 is a specific and efficient substrate of src-family tyrosine kinases.
Cheng HC; Nishio H; Hatase O; Ralph S; Wang JH
J Biol Chem; 1992 May; 267(13):9248-56. PubMed ID: 1577758
[TBL] [Abstract][Full Text] [Related]
4. Development of solid-phase enzyme-linked immunosorbent assays for the determination of epidermal growth factor receptor and pp60c-src tyrosine protein kinase activity.
Farley K; Mett H; McGlynn E; Murray B; Lydon NB
Anal Biochem; 1992 May; 203(1):151-7. PubMed ID: 1381873
[TBL] [Abstract][Full Text] [Related]
5. A nonradioactive dot-blot assay for protein tyrosine kinase activity.
Rijksen G; van Oirschot BA; Staal GE
Anal Biochem; 1989 Oct; 182(1):98-102. PubMed ID: 2481417
[TBL] [Abstract][Full Text] [Related]
6. Fully automated synthesis of (phospho)peptide arrays in microtiter plate wells provides efficient access to protein tyrosine kinase characterization.
Saxinger C; Conrads TP; Goldstein DJ; Veenstra TD
BMC Immunol; 2005 Jan; 6():1. PubMed ID: 15647109
[TBL] [Abstract][Full Text] [Related]
7. A solid-phase assay for the determination of protein tyrosine kinase activity of c-src using scintillating microtitration plates.
Braunwaler AF; Yarwood DR; Hall T; Missbach M; Lipson KE; Sills MA
Anal Biochem; 1996 Feb; 234(1):23-6. PubMed ID: 8742077
[TBL] [Abstract][Full Text] [Related]
8. Activation of Src in human breast tumor cell lines: elevated levels of phosphotyrosine phosphatase activity that preferentially recognizes the Src carboxy terminal negative regulatory tyrosine 530.
Egan C; Pang A; Durda D; Cheng HC; Wang JH; Fujita DJ
Oncogene; 1999 Feb; 18(5):1227-37. PubMed ID: 10022129
[TBL] [Abstract][Full Text] [Related]
9. Description of an enzyme-linked immunosorbent assay for the detection of protein tyrosine kinase.
Lázaro I; Gonzalez M; Roy G; Villar LM; Gonzalez-Porqué P
Anal Biochem; 1991 Feb; 192(2):257-61. PubMed ID: 2035825
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylated residues as specificity determinants for an acidophilic protein tyrosine kinase. A study with src and cdc2 derived phosphopeptides.
Donella-Deana A; Marin O; Brunati AM; Cesaro L; Piutti C; Pinna LA
FEBS Lett; 1993 Sep; 330(2):141-5. PubMed ID: 7689979
[TBL] [Abstract][Full Text] [Related]
11. Measurement of the protein tyrosine kinase activity of c-src using time-resolved fluorometry of europium chelates.
Braunwalder AF; Yarwood DR; Sills MA; Lipson KE
Anal Biochem; 1996 Jul; 238(2):159-64. PubMed ID: 8660605
[TBL] [Abstract][Full Text] [Related]
12. Purification of bovine thymus cytosolic C-terminal Src kinase (CSK) and demonstration of differential efficiencies of phosphorylation and inactivation of p56lyn and pp60c-src by CSK.
Cheng HC; Bjorge JD; Aebersold R; Fujita DJ; Wang JH
Biochemistry; 1996 Sep; 35(36):11874-87. PubMed ID: 8794770
[TBL] [Abstract][Full Text] [Related]
13. Characterization of protein tyrosine kinases from human breast cancer: involvement of the c-src oncogene product.
Ottenhoff-Kalff AE; Rijksen G; van Beurden EA; Hennipman A; Michels AA; Staal GE
Cancer Res; 1992 Sep; 52(17):4773-8. PubMed ID: 1380891
[TBL] [Abstract][Full Text] [Related]
14. PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo.
Ma JG; Huang H; Chen SM; Chen Y; Xin XL; Lin LP; Ding J; Liu H; Meng LH
Breast Cancer Res Treat; 2011 Nov; 130(1):85-96. PubMed ID: 21181437
[TBL] [Abstract][Full Text] [Related]
15. Src kinase regulation by phosphorylation and dephosphorylation.
Roskoski R
Biochem Biophys Res Commun; 2005 May; 331(1):1-14. PubMed ID: 15845350
[TBL] [Abstract][Full Text] [Related]
16. Phosphoinositide 3-kinase-dependent phosphorylation of the dual adaptor for phosphotyrosine and 3-phosphoinositides by the Src family of tyrosine kinase.
Dowler S; Montalvo L; Cantrell D; Morrice N; Alessi DR
Biochem J; 2000 Jul; 349(Pt 2):605-10. PubMed ID: 10880360
[TBL] [Abstract][Full Text] [Related]
17. A microtiter-based assay for the detection of protein tyrosine kinase activity.
Cleaveland JS; Kiener PA; Hammond DJ; Schacter BZ
Anal Biochem; 1990 Nov; 190(2):249-53. PubMed ID: 1705396
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation and externalization of galectin-4 is controlled by Src family kinases.
Ideo H; Hoshi I; Yamashita K; Sakamoto M
Glycobiology; 2013 Dec; 23(12):1452-62. PubMed ID: 24013903
[TBL] [Abstract][Full Text] [Related]
19. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells.
Garcia R; Bowman TL; Niu G; Yu H; Minton S; Muro-Cacho CA; Cox CE; Falcone R; Fairclough R; Parsons S; Laudano A; Gazit A; Levitzki A; Kraker A; Jove R
Oncogene; 2001 May; 20(20):2499-513. PubMed ID: 11420660
[TBL] [Abstract][Full Text] [Related]
20. Activation of Src family kinases in Neu-induced mammary tumors correlates with their association with distinct sets of tyrosine phosphorylated proteins in vivo.
Muthuswamy SK; Muller WJ
Oncogene; 1995 Nov; 11(9):1801-10. PubMed ID: 7478608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
